Pyrronamycin B
Pyrronamycin B has antibacterial activity against Gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. Pyrronamycin B also has anti-tumor activity[1].
Product Specifications
CAS Number
189080-83-9
UNSPSC
12352211
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Smiles
O=C(C1=CC(NC(CNC(NO)=N)=O)=CN1)NC2=CNC(C(NC(C#N)CC(NC(C=O)C/C=C/CN)=O)=O)=C2
Molecular Formula
C23H29N11O6
Molecular Weight
555.55
References & Citations
[1]A Asai, et al. Pyrronamycin A and B, novel antitumor antibiotics containing pyrrole-amide repeating unit, produced by Streptomyces sp. J Antibiot (Tokyo) . 2000 Jan;53 (1) :66-9.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-1433Lsx-1mg 1 mg
Recombinant CTLA-4 Protein (Glu 36-Phe 162) [Fc]
Sign In for Pricing
View Details 
MBS6468024-01 0.1 mL
CR2, CT (Complement Receptor Type 2, Cr2, Complement C3d Receptor, Epstein-Barr Virus Receptor, EBV Receptor, CD21, C3DR) (MaxLight 550)
Sign In for Pricing
View Details MBS6468024-02 5x 0.1 mL
CR2, CT (Complement Receptor Type 2, Cr2, Complement C3d Receptor, Epstein-Barr Virus Receptor, EBV Receptor, CD21, C3DR) (MaxLight 550)
Sign In for Pricing
View Details